ELISA Analyzers Market Size, Share & Trends Analysis Report By Type (Optical Filter Elisa Analyzer, Optical Grating ELISA Analyzers), By Mode, By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global ELISA analyzer market size was valued at USD 567.88 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030. ELISA (Enzyme-linked Immunosorbent Assay) analyzers is a widely used diagnostic tool that allows for detecting and measuring specific proteins and antibodies in a sample. Increasing use of ELISA technology in clinical applications and non-clinical applications such as new drug development, vaccine development, drug monitoring, and others are expected to drive market growth over the forecast period. Moreover, the increasing introduction of technologically advanced analyzers and tests is further anticipated to increase the adoption of these products for different end-use applications.

ELISA analyzers come in different types, including benchtop and microplate readers, and can be customized to suit specific requirements. With the advancement in technology, the introduction of portable devices is increasing and making this technology more accessible to remote areas and point-of-care settings. In May 2022, Molecular Devices, LLC launched automated work cells for ELISA workflows, which streamline and automate the process of ELISA testing, allowing for faster and more efficient analysis of large volumes of samples.

The outbreak of the novel coronavirus (COVID-19) disease has increased the demand for diagnostic solutions, including ELISA analyzers, as it is considered a cornerstone in the management of the pandemic. High demand for immunoassay tests at point-of-care facilities and disease screening has increased the market growth. For instance, in January 2023, a study employed a WANTAI SARS-CoV-2 antibody ELISA kit to measure antibodies against COVID-19 in Malawi. Moreover, in response to the pandemic, several government agencies are focused on mass COVID-19 testing and are undertaking a series of initiatives for expanding analyzers, instruments, and kit volumes to boost the testing rate in their country.

The ELISA analyzers market is driven by the increasing need for advancements in technology and automation in the medical diagnostics industry. A key example of this is the strategic merger of Gold Standard Diagnostics Inc. with Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH in May 2022. It has expanded the company's product portfolio to include automated ELISA analyzers, as it is a widely used diagnostic tool that can detect and measure specific proteins and antibodies in a sample. Moreover, high demand in the diagnosis of diseases such as HIV, hepatitis, and cancer as well as in research fields such as immunology and drug development is driving the growth. Furthermore, automation in instruments is designed to provide accurate and reproducible results, further increasing the demand for these devices.

Type Insights

Optical filter ELISA analyzers is the fastest-growing segment, expected to grow at a CAGR of 4.3% between 2023 and 2030. The growth is attributed to the increasing participation of the players in this segment. For instance, BMG Labtech is one of the players to offer optimal filter, which is made of multi-layer substrates. Hence, increasing the number of players offering these analyzers, enhance the competitiveness of the market and further boosts the market growth of the segment.

Optical grating ELISA analyzers is estimated to capture a considerable market share in 2022. A significant number of applications of grating-type analyzers is considered to be the key growth determinant. For instance, the applications of optical grating ELISA analyzers include microbiological analysis, luciferase analysis, tyrosine kinase assay, dual luciferase analysis, Aequorin Ca2 + Analysis, Chemiluminescence analysis based ELISA, ATP Detection, DNA probes, and dsDNA analysis.

Mode Insights

The automatic ELISA analyzers segment has captured the largest proportion of the market share in 2022 with 58.54% and is expected to maintain dominance with the fastest growth rate over the forecast period. The increase in scientific awareness is driving the demand for automated and portable ELISA analyzers, especially in developing countries. For instance, in endemic areas such as sub-Saharan Africa, portable technologies for the diagnosis of malaria, tuberculosis, West Nile virus, and other infectious diseases are vital to the mitigation of frequent disease outbreaks, which is driving the demand for novel diagnostic solutions.

Moreover, government bodies are also investing heavily to enable the adoption of the latest technologies and curb the high prevalence of various infectious diseases, such as malaria. Thus, propelling the segment growth. However, the penetration of semi-automated devices in developing countries is higher due to the cost-effectiveness of these products.

Application Insights

Vaccine development segment is anticipated to witness the fastest growth rate with a 4.9% CAGR from 2023 to 2030. The COVID-19 pandemic surged the development of vaccines across the globe. For instance, in April 2020, the global COVID-19 vaccine R&D included 115 vaccine candidates, out of these, around 72% of vaccines were developed by private players and 28% were developed as collaborative projects led by the academic, public sector, and other nonprofit organizations. Most of the vaccine development activities were conducted in the North American region with 46% of developers, while 18% of developers were from China, 18% in Asia (excluding China) & Australia, and 18% in Europe.

Immunology is expected to have the largest proportion of the market share in 2022. The increasing R&D investment in immunology-based research is likely to support the growth of the segment during the projected period. For instance, in February 2023, La Jolla Institute for Immunology received funding of USD 17 million from the National Institute of Allergy and Infectious Diseases to develop a data center for human immunology that can assist in immunoprofiling.

End-user Insights

The diagnostic laboratories segment is expected to have the largest market share in 2022 with 42.72%. The largest market share of the segment can be attributed to several advantages, such as they provide fast results (approximately 3-4 hours) with highly sensitive, specific, scalable, cost-effective, and facilitating testing of various types of samples. Increasing inclination toward diagnostic laboratories for gaining fast and cost-effective testing services is expected to be a primary factor driving the demand for ELISA-based solutions, thus boosting segment growth.

Similarly, the Contract Research Organizations (CROs) segment is projected to experience the fastest CAGR during the forecast period. Key companies engage in outsourcing their research & drug development activities to various CROs to obtain a higher profit margin, which is likely to expand their scope of growth over the forecast period. Increasing preference for CROs is a consequence of their associated benefits, which include increased efficiency, cost advantages, enhanced productivity, and a higher focus on core development areas that are critical to a company’s growth.

Regional Insights

North America accounted for the largest share of the ELISA analyzers market in 2022 with 40.50%. The growth in this region can primarily be attributed to the high adoption of technologically advanced ELISA products, favorable reimbursement scenario, and an increase in the prevalence of chronic & infectious diseases. Moreover, the ongoing global pandemic has further propelled the growth of the ELISA analyzers market. High rate of screening tests for COVID-19 and the increasing adoption of immunoassay tests at POC facilities and central labs are some of the key factors that increased the market growth.

Asia Pacific is also witnessing significant growth in the ELISA analyzers market, driven by increasing investments in research and development and the rising prevalence of chronic diseases. For instance, in February 2023, a research team from IIT Delhi developed a COVID-19 vaccine with the assistance of ELISA products to measure antigens, antibodies, or proteins. Hence, the use of ELISA in numerous research is anticipated to enhance the demand for analyzers in the region.  

Key Companies & Market Share Insights

The global ELISA analyzers market is highly competitive, with a large number of players operating in space. These companies have a strong presence in the market, extensive product portfolios, broad geographic reach, and strong distribution networks. Additionally, many of these companies have invested heavily in research & development to stay ahead of the competition and offer their customers the most advanced and innovative ELISA analyzers. Some of the key players in the global ELISA analyzers market include:

• Thermo Fisher Scientific

• Abcam

• Bio-Rad Laboratories

• Merck KGaA

• F. Hoffmann-La Roche Ltd.

• Danaher Corporation

• BioTech

• Agilent Technologies

• QIAGEN

• PerkinElmer Inc.

ELISA Analyzers Market Report Scope

Global ELISA Analyzers Market Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, grand view research has segmented the global ELISA analyzers market report based on type, mode, application, end-user, and region:

• Type Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • Optical Filter ELISA Analyzer

  • Optical Grating ELISA Analyzers

• Mode Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • Automated ELISA Analyzers

  • Semi-Automated ELISA Analyzers

• Application Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • Immunology

  • Vaccine development

  • Drug Monitoring

  • Others

• End-user Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • Biotechnology Companies

  • Pharmaceutical Companies

  • Contract Research Organization

  • Diagnostic Laboratories

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait